EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel topical treatment for dysgeusia/ageusia: a case series report

Joel B Epstein, Arezou Petrie, Geena L Epstein, Andrei Barasch

Supportive Care in Cancer · 2026-09 · 34 (9)

DOI: 10.1007/s00520-026-11080-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Supportive Care in Cancer, online erschienen am 12.08.2026. Verfasst von Joel B Epstein und 3 weiteren Autor:innen. Beteiligte Einrichtung: Oral Medicine Pacific, Beverly Hills, CA, USA. jepstein@coh.org. Hauptthemen laut MEDLINE: Dysgeusia, Memantine, Ageusia. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: City of Hope.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Management of dysgeusia has received limited study despite the significant impact taste has upon general health, nutrition, and quality of life. Taste sensation is initiated at the receptor level, leading to signal transduction and transmission to central taste centers. We assessed the potential of a topical approach to dysgeusia management.

Methods

We report retrospective results of topical application of memantine, gabapentin, and monosodium glutamate (MSG) in a group of 13 patients diagnosed with dysgeusia. Compounded lozenges containing gabapentin 10 mg, memantine 2 mg, and MSG 20 mg in a base of pectin and flavoring were dissolved in the mouth three times daily. Patient-reported changes in gustation were collected. No adverse events were reported.

Results

Eleven patients (85%) reported improved taste that suggests efficacy of the lozenge in improving taste function with local topical application in people that had persisting taste loss despite prior treatment trials.

Conclusions

These findings support the potential of topical intervention for taste management that may have implications in preventive management and intervention for patients with dysgeusia/ageusia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysgeusiaMemantineAgeusiaHumansFemaleRetrospective StudiesAgedMaleMiddle AgedAdministration, TopicalGabapentinSodium Glutamategamma-Aminobutyric AcidAminesCyclohexanecarboxylic AcidsAged, 80 and over

Stichwörter der Autor:innen

AgeusiaDysgeusiaLozenge

Substanzen

GabapentinMemantineSodium Glutamategamma-Aminobutyric AcidAminesCyclohexanecarboxylic Acids

Autor:innen und Institutionen

  • Oral Medicine Pacific, Beverly Hills, CA, USA. jepstein@coh.org.
  • City of Hope, Duarte CA and Cedars-Sinai Medical System Los Angeles, 1500 Duarte Ave, Duarte, CA, 90211, USA. jepstein@coh.org.
  • , Jacksonville, FL, USA.
  • Oral Medicine Pacific, Beverly Hills, CA, USA.
  • Harvard School of Dental Medicine (ret), Boston, MA, USA.

Förderung

  • City of Hope

Zitieren

APA

Epstein, J. B., Petrie, A., Epstein, G. L., & Barasch, A. (2026). Novel topical treatment for dysgeusia/ageusia: a case series report. Supportive Care in Cancer, 34(9). https://doi.org/10.1007/s00520-026-11080-4

Vancouver

Epstein JB, Petrie A, Epstein GL, Barasch A. Novel topical treatment for dysgeusia/ageusia: a case series report. Supportive Care in Cancer. 2026;34(9). doi:10.1007/s00520-026-11080-4

BibTeX
@article{Epstein2026,
  author = {Epstein, Joel B and Petrie, Arezou and Epstein, Geena L and Barasch, Andrei},
  title = {Novel topical treatment for dysgeusia/ageusia: a case series report},
  journal = {Supportive Care in Cancer},
  year = {2026},
  volume = {34},
  number = {9},
  doi = {10.1007/s00520-026-11080-4}
}
Kostenlos starten →